TipRanks
Tvardi Therapeutics (DE:69C)
FRANKFURT:69C
Germany Market
69C
Tvardi Therapeutics
RESEARCH TOOLSreports

Tvardi Therapeutics (69C) Cash flow

1 Followers

Tvardi Therapeutics Cash Flow

DE:69C's free cash flow for Q2 2026 was $-9.23M. For the 2026 fiscal year, DE:69C's free cash flow was decreased by $38.46M and operating cash flow was $-9.23M. See a summary of the company’s cash flow.
Cash Flow
Mar 26Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -23.50M$ -60.92M$ -92.08M$ -17.87M$ -60.09M
Investing Cash Flow
$ -10.08M$ 48.74M$ 43.46M$ -22.00M$ -4.75M
Financing Cash Flow
$ 22.70M$ -3.60M$ 38.15M$ 4.00K$ 46.61M
End Cash Position
$ 20.73M$ 37.90M$ 52.18M$ 21.49M$ 13.45M
Free Cash Flow
$ -23.50M$ -61.96M$ -94.45M$ -17.92M$ -60.13M
Currency in USD

Tvardi Therapeutics Cash Flow